2271-2280 of 2721 results

Class action risk in 2021
Insight 30 Mar 2021

Australia’s class action landscape remains dynamic and complex. 2020 was characterised by an increase in filings, continuing uncertainty around the impact of COVID-19, and a consistently high level of consumer claims. ...

Proposed new responsible lending laws pass the House of Representatives
Insight 23 Mar 2021

On Monday 15 March 2021, the National Consumer Credit Protection Amendment (Supporting Economic Recovery) Bill 2020 passed the House of Representatives, and was introduced in the Senate the following day. This followed the release of the Senate Economics Legislation Committee Report on the Bill. ...

Nucleus – corporate law developments: ASIC restricts effectiveness of certain director resignations; new ASIC whistleblower immunity policy; and other updates
Insight 21 Mar 2021

ASIC restricts effectiveness of director resignations and introduces new whistleblower immunity policy; FIRB commences evaluation of changes to foreign investment laws; ACCC flags further reform of merger review process in 2021; lapsing of electronic signing and virtual meeting protocols ...

Will negative price risk increase following changes to dispatch obligations under the National Electricity Rules?
Insight 25 Mar 2021

Semi-scheduled generators, such as wind and solar farms, will face increased exposure to negative price risk following a new rule made by the Australian Energy Market Commission (AEMC). ...

ACCC's 2021 product safety priorities
Insight 29 Mar 2021

The ACCC announced its Product Safety Priorities for 2021, including: Button batteries, Quad bikes, Toppling furniture and infant sleeping products, and E-commerce and the Australian Product Safety Pledge. ...

Repurposing existing medicines – industry to have its say in reshaping Australia's regulatory future
Insight 25 Mar 2021

The Therapeutics Goods Administration (the TGA) is consulting with the public and industry to potentially reform regulatory and reimbursement frameworks, to incentivise the repurposing of existing medicines. Off-label use (where a medicine is used for a disease or medical condition for which it does ...

Allens advises Investec on sale of $1.1bn loan portfolio
News 29 Mar 2021

The portfolio comprises leveraged finance, corporate and fund finance loans to corporates and funds across business services, entertainment, retail, childcare, healthcare, mining services and ...

NSW becomes the second Australian jurisdiction to pass a PFAS ban
Insight 02 Mar 2021

Knowledge of the risks posed by PFAS (per- and poly-fluoroalkyl substances), its behaviour in the environment and potential PFAS remediation options continue to evolve rapidly. Following South Australia's PFAS ban in 2018, New South Wales has just passed regulations to restrict the sale and use of PFAS firefighting foam. ...

The role of banking in the infrastructure-led recovery
Insight 09 Mar 2021

Banks have played, and will continue to play, a key role in not only supporting Australian individuals and businesses managing the effects of the pandemic, but also as a key capital provider in the investment of new infrastructure for a post-pandemic world. ...

National Electricity and Gas rules update: February 2021
Insight 16 Mar 2021

In our latest update, we examine the progress of new and existing rule change requests to the AEMC across the month of February, as well as take a closer look at the release of Victoria's Renewable Energy Zones Development Plan. ...

Refine